Member Log In
Need help logging in?

PIA Overview:
Blood-Based Biomarkers

Chairs: Michelle Mielke

The purpose of this PIA is to establish validated blood based biomarkers for use in research settings, clinical trials, diagnostics and clinical practice.

This PIA will:

  1. Create standards and guidelines for the development of novel blood biomarkers of use in Alzheimer's disease and conditions related to cognitive decline.
  2. Create a global working group designed to advance the field of blood-based biomarkers of Alzheimer's disease.
  3. Develop a central data repository and sample bank network to foster innovation and validation of blood biomarkers for Alzheimer's disease.


View the calendar for this PIA's events »
Join ISTAART. Gain PIA Access. »